SCHEMBL12164115

SCHEMBL12164115

CCN(C)c1nc(SCc2coc(-c3ccc(Cl)cc3)n2)c(C#N)c(-c2ccc(CCCO)cc2)c1C#N

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 11/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ RET P07949 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ ALOX15 P16050 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12163894 0.92 ADORA1 (0.41) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12553108 0.88 ADORA1 (0.53) ADORA1SLC6A3MAPTNPSR1KDM4E
SCHEMBL13938791 0.87 ADORA1 (0.45) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL10194492 0.86 ADORA1 (0.54) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12164040 0.86 ADORA1 (0.42) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12163902 0.85 ADORA1 (0.41) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12163892 0.82 NPSR1 (0.47) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12163893 0.81 ADORA1 (0.42) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12164106 0.80 ADORA1 (0.43) ADORA1SLC6A3RETLMNAMAPT
SCHEMBL12552992 0.80 ADORA1 (0.52) ADORA1SLC6A3MAPTNPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185550-B1 SUBSTITUTED ARYLOXAZOLES AND THE USE THEREOF Bayer Pharma AG (DE) 2011-11-02 — — EP disclosed
Send feedback